Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1968 1
1970 2
2004 2
2005 2
2006 3
2007 6
2008 5
2009 11
2010 11
2011 5
2012 8
2013 14
2014 6
2015 18
2016 36
2017 35
2018 44
2019 31
2020 44
2021 40
2022 40
2023 45
2024 42
2025 45
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

450 results

Results by year

Filters applied: . Clear all
Page 1
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance.
Jabban Y, He R, Bessonen K, Greipp P, Jevremovic D, Viswanatha DS, Foran JM, Badar T, Yi CA, Kusne YN, Saliba AN, Hefazi M, Matin A, Hogan WJ, Mangaonkar AA, Shah MV, Alkhateeb HB, Patnaik MM, Al-Kali A. Jabban Y, et al. Among authors: patnaik mm. Br J Haematol. 2026 Feb 25. doi: 10.1111/bjh.70398. Online ahead of print. Br J Haematol. 2026. PMID: 41738526 No abstract available.
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent.
Gangat N, Warraich M, Kumar S, Fatima M, McCullough K, Begna KH, Al-Kali A, Patnaik MM, Hogan WJ, Mangaonkar A, Saliba AN, Torghabeh MH, Alkhateeb H, Shah MV, Foran JM, Badar T, Palmer JM, Yi CA, Pardanani A, Tefferi A. Gangat N, et al. Among authors: patnaik mm. Am J Hematol. 2026 Feb 18. doi: 10.1002/ajh.70248. Online ahead of print. Am J Hematol. 2026. PMID: 41708842
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia.
Montalban-Bravo G, Wu C, Rodriguez-Sevilla JJ, Wei Y, Chien KS, Bouligny I, Kanagal-Shamanna R, Li Z, Natu A, Gurney M, Bazinet A, Hammond D, Bataller A, Borthakur G, Short NJ, DiNardo CD, Kadia TM, Ravandi F, Daver N, Pemmaraju N, Jabbour E, Issa GC, Wang SA, Patel KP, Tang G, Medeiros LJ, Lasho TL, Finke CM, Al-Kali A, Csizmar CM, Alkhateeb H, Gangat N, Mangaonkar AA, Roman-Bravo D, Arenillas L, Tefferi A, Kantarjian HM, Garcia-Manero G, Calvo X, Patnaik MM, Loghavi S. Montalban-Bravo G, et al. Among authors: patnaik mm. Blood Cancer Discov. 2026 Jan 26. doi: 10.1158/2643-3230.BCD-25-0264. Online ahead of print. Blood Cancer Discov. 2026. PMID: 41587375
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromes.
Aldapt M, Wang YH, Shah KJ, El Kettani M, Foran J, Kharfan-Dabaja M, Murthy H, Al-Kali A, Shah MV, Alkhateeb H, Saliba AN, Hogan W, Yi CA, Sproat L, Punwani N, Khera N, Palmer J, Litzow M, Tefferi A, Gangat N, Patnaik MM, Badar T. Aldapt M, et al. Among authors: patnaik mm. Haematologica. 2026 Jan 8. doi: 10.3324/haematol.2025.289268. Online ahead of print. Haematologica. 2026. PMID: 41504247 Free article.
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.
Badar T, Marando L, Latorre E, Lasho T, Olivia FD, Lin C, McCormick BJ, El Kettani M, Shah KJ, Kusne Y, Jamy O, Diebold K, Coltoff A, Finke C, Foran J, Kharfan-Dabaja M, Fan YS, Jiang L, He R, Thomas M, Patel A, Viswanatha D, Shah MV, Saliba A, Mangaonkar A, Kirschner K, Al-Kali A, Gangat N, Litzow M, Patnaik MM. Badar T, et al. Among authors: patnaik mm. Blood Adv. 2026 Mar 10;10(5):1746-1755. doi: 10.1182/bloodadvances.2025018031. Blood Adv. 2026. PMID: 41499760 Free PMC article.
Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s).
Wang SA, Ok CY, Tsai HK, Loayza N, Daneshpajouhnejad P, Seth N, Cantu MD, Bagg A, Tam W, Weinberg O, Barone PD, Geyer JT, Lindsley CR, Montalban-Bravo G, Simon CR, Arber DA, Bueso-Ramos CE, Hsi ED, Foucar K, Orazi A, Patnaik MM, Hasserjian RP, Reichard KK. Wang SA, et al. Among authors: patnaik mm. Haematologica. 2025 Dec 24. doi: 10.3324/haematol.2025.288906. Online ahead of print. Haematologica. 2025. PMID: 41437825 Free article.
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancer.
Ogbue O, Kusne Y, Mosalem O, Thompson K, Ferrer A, Kalari K, Tan W, Jones LA, Costello BA, Childs D, Mangaonkar AA, Fernandez JA, Finke C, Lasho TL, Weinshilboum R, Wang L, Patnaik MM. Ogbue O, et al. Among authors: patnaik mm. Haematologica. 2025 Dec 4. doi: 10.3324/haematol.2025.288975. Online ahead of print. Haematologica. 2025. PMID: 41342202 Free article.
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL).
Boddicker NJ, Shanafelt TD, Parikh SA, Rabe KG, Griffin R, Norman AD, Yao Y, Tian S, Ma T, O'Brien DR, Vallejo BA, Hoel MS, Lehman SJ, Olson JE, Hampel PJ, Braggio E, Patnaik MM, Cerhan JR, Vachon CM, Hanson CA, Slager SL. Boddicker NJ, et al. Among authors: patnaik mm. Blood Cancer J. 2025 Nov 6;15(1):195. doi: 10.1038/s41408-025-01385-8. Blood Cancer J. 2025. PMID: 41198626 Free PMC article.
450 results